Formulation Development

Mycenax delivers rapid and comprehensive drug product development, specializing in liquid and lyophilized formulations for diverse biotherapeutics.

Offering end-to-end solutions, from drug substance to drug product, we ensure maximized filling success with expert drug process development and a wide range of dosage form expertise, including vials and prefilled syringes.

 

Highlights of formulation development experience:

 

 

Comprehensive experience in various of dosage form: liquid vial, lyophilized vial, PFS, and cartridge

 

Successful formulation projects for different biotherapeutics: mAb, fusion protein, ADC and etc

 

FAST TRACK drug product development strategies to accelerate your drug development

 

 

     

Comprehensive Drug Product Development Expertise

 

We provide comprehensive dosage form design and development services, leveraging our extensive experience across all phases of clinical development. Our capabilities span a wide range of therapeutic modalities, including antibodies, bispecific antibodies, and emerging therapies like exosomes and recombinant proteins, with experience in lyophilized formulations and various container formats, including vials and pre-filled syringes.

 
 
 
 

End-to-End Drug Product Development Strategies

 

Mycenax offers formulation development services tailored to various biotherapeutic product types, addressing the needs at every stage of the product lifecycle, including pre-IND, clinical stages, and post-market phases. In the pre-IND phase, we provide formulation development by making informed decisions based on a deep understanding of the product's properties and characteristics. Both Design of Experiments (DOE) and One Factor at a Time (OFAT) approaches are utilized based on the design. Liquid formulations and lyophilized forms can be developed at the lab scale and scaled up to manufacturing levels.

 

Our expert team has experience in formulation development across various product types. Based on the drug development lifecycle, Mycenax offers FAST TRACK solutions with the following services:

  • Product Oriented Formulation Development and Optimization
  • Drug Product Process Development
 
 

Maximizing Filling Success: Drug Process Development Services

 

To maximize a successful and expedited filling process, drug process development must be carried out prior to product filling. Our expert team offers the following services to confirm the product's stability during the filling process and its compatibility with the filling line materials.

 
 

 

 

 

 

Mycenax delivers rapid and comprehensive drug product development, specializing in liquid and lyophilized formulations for diverse biotherapeutics.

Offering end-to-end solutions, from drug substance to drug product, we ensure maximized filling success with expert drug process development and a wide range of dosage form expertise, including vials and prefilled syringes.

 

Highlights of formulation development experience:

 

 

 

Comprehensive experience in various of dosage form: liquid vial, lyophilized vial, PFS, and cartridge

 

Successful formulation projects for different biotherapeutics: mAb, fusion protein, ADC and etc

 

FAST TRACK drug product development strategies to accelerate your drug development

 
   
   

Comprehensive Drug Product Development Expertise

 
   

We provide comprehensive dosage form design and development services, leveraging our extensive experience across all phases of clinical development. Our capabilities span a wide range of therapeutic modalities, including antibodies, bispecific antibodies, and emerging therapies like exosomes and recombinant proteins, with experience in lyophilized formulations and various container formats, including vials and pre-filled syringes.

 
   
 
   
 
   

End-to-End Drug Product Development Strategies

 
   

Mycenax offers formulation development services tailored to various biotherapeutic product types, addressing the needs at every stage of the product lifecycle, including pre-IND, clinical stages, and post-market phases. In the pre-IND phase, we provide formulation development by making informed decisions based on a deep understanding of the product's properties and characteristics. Both Design of Experiments (DOE) and One Factor at a Time (OFAT) approaches are utilized based on the design. Liquid formulations and lyophilized forms can be developed at the lab scale and scaled up to manufacturing levels.

 
   

Our expert team has experience in formulation development across various product types. Based on the drug development lifecycle, Mycenax offers FAST TRACK solutions with the following services:

  • Product Oriented Formulation Development and Optimization
  • Drug Product Process Development
 
   
 
   

Maximizing Filling Success: Drug Process Development Services

 
   

To maximize a successful and expedited filling process, drug process development must be carried out prior to product filling. Our expert team offers the following services to confirm the product's stability during the filling process and its compatibility with the filling line materials.

 
   
 
   
 

 

確認送出 SEND
GO TOP